Core Laboratories (CLB)
(Delayed Data from NYSE)
$16.98 USD
+0.65 (3.98%)
Updated Aug 18, 2022 04:00 PM ET
After-Market: $16.98 +0.02 (0.12%) 4:18 PM ET
3-Hold of 5 3
B Value D Growth D Momentum D VGM
Fundamental Charts
About Earnings Yield (TTM)
The company's trailing twelve month (TTM) Earning Yield is used to determine whether the company is undervalued or overvalued. The Earning yield an indicator of the company's earnings and the price paid for the stock. The calculation is the inverse of the P/E ratio. The most common use of the Earnings ratio is to compare it to other stocks and to compare the yields to the 10 Year T-Bill. If earnings go up, the yield goes up. If earnings go down, so does the yield. For example: If the yield on the S&P 500 is greater than the 10 Year T-Bill, stocks would be considered undervalued.
CLB 16.98 +0.65(3.98%)
Will CLB be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CLB based on the 1-3 month trading system that nearly triples the S&P 500.
Zacks News for CLB
SLB or CLB: Which Is the Better Value Stock Right Now?
Core Labs (CLB) Q2 Earnings Meet Estimates, Sales Narrowly Beat
CLB: What are Zacks experts saying now?
Zacks Private Portfolio Services
Core Laboratories (CLB) Q2 Earnings Match Estimates
Earnings Preview: Core Laboratories (CLB) Q2 Earnings Expected to Decline
Implied Volatility Surging for Core Laboratories (CLB) Stock Options
Other News for CLB
Christina Lake Cannabis Corp. Recaps Second Quarter Results
Christina Lake Cannabis Appoints Experienced Cannabis Executive Mark Aiken as CEO
Core Laboratories` (CLB) CEO Larry Bruno on Q2 2022 Results - Earnings Call Transcript
Core Laboratories: Q2 Earnings Snapshot
CORE LAB REPORTS SECOND QUARTER 2022 RESULTS FROM CONTINUING OPERATIONS